Off-label use of rituximab for systemic lupus erythematosus in Europe.


Ryden-Aulin M., Boumpas D., Bultink I., Rubio J. L. C. , Caminal-Montero L., Castro A., ...More

Lupus science & medicine, vol.3, no.1, 2016 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 3 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.1136/lupus-2016-000163
  • Journal Name: Lupus science & medicine
  • Journal Indexes: Scopus

Abstract

Objectives: Rituximab (RTX) is a biological treatment used off-label in patients with systemic lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in Europe and compare the characteristics of patients receiving RTX with those receiving conventional therapy.